NT5E and neoplasm: In particular, the majority (65–91% in tumor vs 36–56% in spleen) of tumor-infiltrating CD11b+ myeloid cells express the two receptors, due to an increase in expression of CD73, given that those cells are normally CD39+ (figure 2A,B).